Sec Form 13D Filing - 210 Capital, LLC filing for P10, Inc. (PX) - 2024-12-20

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D



Comment for Type of Reporting Person:
(1) These shares include 4,954,397 shares of Class A common stock, all of which may be deemed to be beneficially owned by each Reporting Person.(2) The percentage is based on the sum of (i) 54,850,578 shares of Class A common stock outstanding as of November 4, 2024, as reported on the Issuer's Quarterly Report on Form 10-Q, filed on November 8, 2024, plus (ii) 2,000,000 shares of Class A common stock issued upon conversion by the Reporting Persons of an equivalent number of shares Class B common stock effective November 20, 2024, plus (iii) 2,000,000 shares of Class A common stock issued upon conversion by the Reporting Persons of an equivalent number of shares Class B common stock effective November 25, 2024, plus (iv) 700,000 shares of Class A common stock issued upon conversion by the Reporting Persons of an equivalent number of shares Class B common stock effective December 4, 2024, plus (v) 4,967,397 shares of Class A common stock issued upon conversion by the Reporting Persons of an equivalent number of shares Class B common stock effective December 18, 2024.


SCHEDULE 13D



Comment for Type of Reporting Person:
(1) These shares include 4,954,397 shares of Class A common stock, all of which may be deemed to be beneficially owned by each Reporting Person.(2) The percentage is based on the sum of (i) 54,850,578 shares of Class A common stock outstanding as of November 4, 2024, as reported on the Issuer's Quarterly Report on Form 10-Q, filed on November 8, 2024, plus (ii) 2,000,000 shares of Class A common stock issued upon conversion by the Reporting Persons of an equivalent number of shares Class B common stock effective November 20, 2024, plus (iii) 2,000,000 shares of Class A common stock issued upon conversion by the Reporting Persons of an equivalent number of shares Class B common stock effective November 25, 2024, plus (iv) 700,000 shares of Class A common stock issued upon conversion by the Reporting Persons of an equivalent number of shares Class B common stock effective December 4, 2024, plus (v) 4,967,397 shares of Class A common stock issued upon conversion by the Reporting Persons of an equivalent number of shares Class B common stock effective December 18, 2024.


SCHEDULE 13D



Comment for Type of Reporting Person:
(1) These shares include 4,954,397 shares of Class A common stock, all of which may be deemed to be beneficially owned by each Reporting Person.(2) The percentage is based on the sum of (i) 54,850,578 shares of Class A common stock outstanding as of November 4, 2024, as reported on the Issuer's Quarterly Report on Form 10-Q, filed on November 8, 2024, plus (ii) 2,000,000 shares of Class A common stock issued upon conversion by the Reporting Persons of an equivalent number of shares Class B common stock effective November 20, 2024, plus (iii) 2,000,000 shares of Class A common stock issued upon conversion by the Reporting Persons of an equivalent number of shares Class B common stock effective November 25, 2024, plus (iv) 700,000 shares of Class A common stock issued upon conversion by the Reporting Persons of an equivalent number of shares Class B common stock effective December 4, 2024, plus (v) 4,967,397 shares of Class A common stock issued upon conversion by the Reporting Persons of an equivalent number of shares Class B common stock effective December 18, 2024.


SCHEDULE 13D



Comment for Type of Reporting Person:
(1) These shares include 4,954,397 shares of Class A common stock, all of which may be deemed to be beneficially owned by each Reporting Person.(2) The percentage is based on the sum of (i) 54,850,578 shares of Class A common stock outstanding as of November 4, 2024, as reported on the Issuer's Quarterly Report on Form 10-Q, filed on November 8, 2024, plus (ii) 2,000,000 shares of Class A common stock issued upon conversion by the Reporting Persons of an equivalent number of shares Class B common stock effective November 20, 2024, plus (iii) 2,000,000 shares of Class A common stock issued upon conversion by the Reporting Persons of an equivalent number of shares Class B common stock effective November 25, 2024, plus (iv) 700,000 shares of Class A common stock issued upon conversion by the Reporting Persons of an equivalent number of shares Class B common stock effective December 4, 2024, plus (v) 4,967,397 shares of Class A common stock issued upon conversion by the Reporting Persons of an equivalent number of shares Class B common stock effective December 18, 2024.


SCHEDULE 13D



Comment for Type of Reporting Person:
(1) These shares include 4,954,397 shares of Class A common stock, all of which may be deemed to be beneficially owned by each Reporting Person.(2) The percentage is based on the sum of (i) 54,850,578 shares of Class A common stock outstanding as of November 4, 2024, as reported on the Issuer's Quarterly Report on Form 10-Q, filed on November 8, 2024, plus (ii) 2,000,000 shares of Class A common stock issued upon conversion by the Reporting Persons of an equivalent number of shares Class B common stock effective November 20, 2024, plus (iii) 2,000,000 shares of Class A common stock issued upon conversion by the Reporting Persons of an equivalent number of shares Class B common stock effective November 25, 2024, plus (iv) 700,000 shares of Class A common stock issued upon conversion by the Reporting Persons of an equivalent number of shares Class B common stock effective December 4, 2024, plus (v) 4,967,397 shares of Class A common stock issued upon conversion by the Reporting Persons of an equivalent number of shares Class B common stock effective December 18, 2024.


SCHEDULE 13D



Comment for Type of Reporting Person:
(1)The sole amounts include includes 425,093 shares of Class A common stock underlying stock options held by the Reporting Person that are exercisable within 60 days of the date hereof.(2)The shared amounts include 4,954,397 shares of Class A common stock, all of which may be deemed to be beneficially owned by each Reporting Person.(3)The percentage is based on the sum of (i) 54,850,578 shares of Class A common stock outstanding as of November 4, 2024, as reported on the Issuer's Quarterly Report on Form 10-Q, filed on November 8, 2024, plus (ii) 2,000,000 shares of Class A common stock issued upon conversion by the Reporting Persons of an equivalent number of shares Class B common stock effective November 20, 2024, plus (iii) 2,000,000 shares of Class A common stock issued upon conversion by the Reporting Persons of an equivalent number of shares Class B common stock effective November 25, 2024, plus (iv) 700,000 shares of Class A common stock issued upon conversion by the Reporting Persons of an equivalent number of shares Class B common stock effective December 4, 2024, plus (v) 4,967,397 shares of Class A common stock issued upon conversion by the Reporting Persons of an equivalent number of shares Class B common stock effective December 18, 2024, plus (vi) 425,093 shares of Class A common stock underlying stock options held by Mr. Alpert that are exercisable as of the date hereof.


SCHEDULE 13D



Comment for Type of Reporting Person:
(1)The sole amounts include includes 425,093 shares of Class A common stock underlying stock options held by the Reporting Person that are exercisable within 60 days of the date hereof(2)The shared amounts include 4,954,397 shares of Class A common stock, all of which may be deemed to be beneficially owned by each Reporting Person.(3)The percentage is based on the sum of (i) 54,850,578 shares of Class A common stock outstanding as of November 4, 2024, as reported on the Issuer's Quarterly Report on Form 10-Q, filed on November 8, 2024, plus (ii) 2,000,000 shares of Class A common stock issued upon conversion by the Reporting Persons of an equivalent number of shares Class B common stock effective November 20, 2024, plus (iii) 2,000,000 shares of Class A common stock issued upon conversion by the Reporting Persons of an equivalent number of shares Class B common stock effective November 25, 2024, plus (iv) 700,000 shares of Class A common stock issued upon conversion by the Reporting Persons of an equivalent number of shares Class B common stock effective December 4, 2024, plus (v) 4,967,397 shares of Class A common stock issued upon conversion by the Reporting Persons of an equivalent number of shares Class B common stock effective December 18, 2024, plus (vi) 425,093 shares of Class A common stock underlying stock options held by Mr. Alpert that are exercisable as of the date hereof.EXPLANATORY NOTEThis Amendment No. 7 to Schedule 13D (this Amendment) amends the items included herein that were contained in the Schedule 13D filed on December 20, 2023, as amended by Amendment No. 1 filed October 8, 2024, Amendment No. 2 filed November 12, 2024, Amendment No. 3 filed November 22, 2024, Amendment No. 4 filed November 27, 2024, Amendment No. 5 filed December 5, 2024, and Amendment No. 6 filed December 13, 2024 (the Original Schedule 13D, and together with this Amendment, this Schedule 13D) relating to shares of Class A common stock, par value $0.001 per shares, and shares of Class B common stock, par value $0.001 per shares, of P10, Inc., a Delaware corporation (the Issuer), filed by: (i) 210/P10 Acquisition Partners, LLC, a Texas limited liability company (210/P10); (ii) 210 Capital, LLC, a Delaware limited liability company (210 Capital); (iii) Covenant RHA Partners, L.P., a Texas limited partnership (RHA Partners); (iv) CCW/LAW Holdings, LLC, a Texas limited liability company (CCW Holdings); (v) RHA Investments, Inc., a Texas corporation (RHA Investments); (vi) Robert Alpert; and (vii) C. Clark Webb (each, a Reporting Person and collectively, the Reporting Persons).On December 18, 2024, the Reporting Persons: (i) converted 4,967,397 shares of Class B common stock into an equivalent number of shares Class A common stock; and (ii) entered into an amendment to the Controlled Company Agreement (as defined in the Original Schedule 13D) that removed the Reporting Persons as a party thereto. This Amendment is being filed to reflect the foregoing changes and to update the information regarding the beneficial ownership of the shares of Class A common stock of the Issuer held by the Reporting Persons.Except as specifically provided herein, this Amendment does not modify any of the information previously reported in the Original Schedule 13D. Capitalized terms used but not defined in this Amendment shall have the same meanings ascribed to them in the Original Schedule 13D.


SCHEDULE 13D

 
210 Capital, LLC
 
Signature:/s/ Robert Alpert
Name/Title:Authorized Signatory
Date:12/20/2024
 
210/P10 Acquisition Partners, LLC
 
Signature:/s/ Robert Alpert
Name/Title:Authorized Signatory of 210 Capital, LLC, its Member
Date:12/20/2024
 
CCW/LAW Holdings, LLC
 
Signature:/s/ C. Clark Webb
Name/Title:Authorized Signatory
Date:12/20/2024
 
Covenant RHA Partners, L.P.
 
Signature:/s/ Robert Alpert
Name/Title:Authorized Signatory of RHA Investments, Inc., its Member
Date:12/20/2024
 
RHA Investments, Inc.
 
Signature:/s/ Robert Alpert
Name/Title:Authorized Signatory
Date:12/20/2024
 
Robert Alpert
 
Signature:/s/ Robert Alpert
Name/Title:Robert Alpert
Date:12/20/2024
 
C. Clark Webb
 
Signature:/s/ C. Clark Webb
Name/Title:C. Clark Webb
Date:12/20/2024
primary_doc.xml